LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 31.30 | 56.33 | 1359 | 2241 | 0.6137 | 0.7779 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 33.00 | 56.33 | 1455 | 2479 | 0.5948 | 0.7745 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 34.70 | 56.33 | 1535 | 2720 | 0.5716 | 0.7695 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 36.40 | 56.33 | 1589 | 2958 | 0.5437 | 0.7597 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 38.10 | 56.33 | 1681 | 3168 | 0.5369 | 0.7545 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.80 | 56.33 | 1755 | 3393 | 0.5221 | 0.7503 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.50 | 56.33 | 1834 | 3667 | 0.5054 | 0.7470 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 43.20 | 56.33 | 1937 | 3942 | 0.4960 | 0.7453 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 44.90 | 56.33 | 2039 | 4212 | 0.4877 | 0.7475 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.60 | 56.33 | 2150 | 4538 | 0.4785 | 0.7475 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 48.30 | 56.33 | 2245 | 4875 | 0.4654 | 0.7438 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 50.00 | 56.33 | 2351 | 5234 | 0.4526 | 0.7404 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 51.70 | 56.33 | 2460 | 5553 | 0.4464 | 0.7406 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.40 | 56.33 | 2583 | 5809 | 0.4479 | 0.7448 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 55.10 | 56.33 | 2684 | 6087 | 0.4443 | 0.7428 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.80 | 56.33 | 2806 | 6354 | 0.4463 | 0.7459 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.50 | 56.33 | 2911 | 6599 | 0.4468 | 0.7457 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.20 | 56.33 | 3042 | 6852 | 0.4506 | 0.7484 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 61.90 | 56.33 | 3137 | 7075 | 0.4510 | 0.7492 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.60 | 56.33 | 3259 | 7339 | 0.4514 | 0.7506 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 65.30 | 56.33 | 3366 | 7570 | 0.4520 | 0.7514 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 67.00 | 56.33 | 3466 | 7731 | 0.4569 | 0.7556 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 68.70 | 56.33 | 3547 | 7933 | 0.4554 | 0.7544 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 70.50 | 56.33 | 3528 | 7990 | 0.4492 | 0.7456 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 72.20 | 56.33 | 3539 | 8053 | 0.4464 | 0.7435 |